{
  "specialty": "Hematology",
  "condition": "vte_thrombophilia",
  "template_name": "hematology_vte_thrombophilia",
  "sections": [
    {
      "The following situations are generally inappropriate for VTE/Thrombophilia eConsult [PLEASE PLACE AN IN-PERSON REFERRAL INSTEAD]": [
        "Recurrent VTE",
        "Cancer-associated thrombosis",
        "Pregnancy",
        "Autoimmune disease",
        "History of both arterial and venous thrombosis",
        "Presence of an IVC Filter"
      ]
    },
    {
      "My Clinical Question (condition: VTE/Thrombophilia)": "***"
    },
    {
      "My most current assessment of this problem can be found in the note dated": "{Today/***}"
    },
    {
      "In your clinical question, or current note, please include information on": {
        "Assessments": {
          "Required": [
            {
              "Risk factors for VTE present (make sure to document all: family history, weight, prior VTE, lower extremity exam, updated medication list, age-appropriate cancer screening)": "***"
            },
            {
              "Imaging or radiology report of VTE": "***"
            }
          ],
          "Optional": []
        },
        "Diagnostics": {
          "Required": [
            {
              "CBC with diff (on two consecutive checks at least one week apart)": "***"
            },
            {
              "CMP": "***"
            },
            {
              "Ferritin": "***"
            }
          ],
          "Optional": []
        },
        "Clinical Pearls": [
          {
            "Therapy guideline:  https://depts.washington.edu/anticoag/home/": [
              {
                "Superficial thrombophlebitis \u2013 prophylactic dose for 6 weeks if high-risk": "***"
              },
              {
                "Line-associated DVT \u2013 3 months or until line out, whichever longer": "***"
              },
              {
                "Distal DVT \u2013 3 months (unless anticoagulation-averse, asymptomatic, low-risk, then serial US)": "***"
              },
              {
                "Proximal DVT \u2013 3-6 months at the minimum": "***"
              }
            ]
          },
          {
            "In most circumstances, we do not perform thrombophilia screening or specific management for patients > 45 years old": "***"
          },
          {
            "Avoid testing antithrombin, protein C, protein S during acute thrombosis or active anticoagulation": "***"
          },
          {
            "Uncommon causes of hypercoagulability (especially if presenting with splanchnic vein thrombosis or cerebral venous sinus thrombosis) include JAK2 mutation and paroxysmal nocturnal hemoglobinuria": "***"
          },
          {
            "Consider screening for proteinuria for nephrotic syndrome": "***"
          },
          {
            "Consider testing for antiphospholipid syndrome": "***"
          },
          {
            "We generally recommend that incidental PE or subsegmental PE be treated as a standard PE": "***"
          },
          {
            "For provoked VTE due to a surgical risk factor, we recommend finite anticoagulation due to low risk of recurrence": "***"
          },
          {
            "Unprovoked VTE are generally treated indefinitely assuming the bleeding risk is low although should be discussed with hematology further": "***"
          },
          {
            "The superficial femoral vein is a deep vein!": "***"
          }
        ]
      }
    }
  ]
}